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Objective: The purpose of this study was to examine the association between body mass index (BMI), venous capacitance,
and clinical evidence of varicose veins after adjustment for sex hormones in postmenopausal women.
Methods: This study group of the DIANA (DIet and ANdrogens) project (a randomized controlled trial on the effect of
some dietary changes on sex hormone pattern in women with elevated androgenic hormone levels in Italy) was comprised
of 104 healthy volunteer postmenopausal women, aged 48 to 65 years. The main outcome measures were physical
examination to determine the presence and severity of varicose veins and plethysmographic measurement of lower limb
venous capacitance and outflow.
Results: Women in the upper quartile of BMI (>30 kg/m2) showed a positive association with clinical evidence of varicose
veins (odds ration, 5.8; 95% CI, 1.2 to 28.2) after adjustment for age, estradiol, testosterone, and sex hormone binding
globulin. No association was found between BMI and plethysmographic measurements of venous parameters.
Conclusion: Obesity is associated with clinical evidence of varicose veins independently from the influence of sex hormones
in postmenopausal women and is not associated with venous capacitance. Increased body weight increases the risk of
varicose veins. (J Vasc Surg 2002;36:965-8.)
Venous disease of the lower limbs is a major problem
affecting Western societies that results in considerable mor-
bidity in the population and cost to the healthcare service.1
Many epidemiologic studies on the prevalence of varicose
veins have found an association between body mass index
(BMI) and presence of varicose veins.2-4 Other factors
could play a role in the development of varicose veins,
particularly sex hormone patterns.5 To our knowledge, no
study has investigated the association between BMI, vari-
cose veins, and lower limb venous compliance, taking into
account the concentration of sexual hormones of the indi-
viduals participating in the study.
One of the factors associated with primary venous
dysfunction is an abnormal venous wall distensibility.6 Es-
trogens promote the appearance of varicose veins because
of an increased venous capacitance.5 Strain-gauge plethys-
mography is one of the best available methods to study
maximal venous capacitance.7 In this study, we evaluated
the relationships among BMI, clinical evidence of varicose
veins, and plethysmographic measurement of venous ca-
pacitance, after controlling for age and sex hormone pat-
tern (ie, serum estradiol, sex hormone binding globulin
[SHBG], and testosterone), in a group of healthy post-
menopausal women to clarify the role of obesity in the
pathogenesis of venous dysfunction in the lower limbs.
PARTICIPANTS AND METHODS
Subjects. Progetto DIANA (DIet and ANdrogens) is
a nutritional trial in the Milan area, Northern Italy, within
the research activities of the Epidemiology Unit of the
National Cancer Institute. The general objective of the
project was to test the effect of a specific diet on the levels of
serum testosterone together with other effects on sex and
metabolic hormones in healthy female volunteers aged 48
to 65 years invited through newspapers and broadcasting
advertisements.8 Potential participants had to fulfill the
following conditions: postmenopausal for at least 2 years,
no history of ovariectomy, no hormonal replacement treat-
ment for at least 6 months, no history of cancer or vascular
disease (in particular no previous venous thromboembo-
lism), no adherence to vegetarian or macrobiotic diet or to
any other diet prescribed for medical reasons, no treatment
for diabetes, and agreement of participation in the study
with informed consent.
Three hundred and twelve women were recruited.
However, because one of the main objectives of this project
was to reduce testosterone levels through a nutritional
approach, 104 were selected to participate in the trial on the
basis of their serum testosterone levels (included in the
upper tertile). An ancillary study of this nutritional project
examined the relationship of varicose vein prevalence and
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lower limb venous function with BMI in this group of
women before the trial started.
Written informed consent to participate in the study for
research purposes was obtained from all women before
enrollment. The Scientific and Ethical Committee of the
National Cancer Institute, Milan, Italy, approved the re-
search with human volunteers.
Design. Baseline observation of all the women re-
cruited in the study included a physical examination for
diagnosis and classification of varicose veins, a venous
strain-gauge plethysmographic measurement of venous ca-
pacitance and outflow, standard anthropometric measure-
ments, and blood sample collection.
Laboratory analyses. Blood samples were collected
from the patients in the morning after an overnight fast.
Serum for hormonal assays was stored at30° C for a short
time and then at 80° C. Circulating hormones were
measured with commercial kits: RIA kits were purchased
from ORION Diagnostic (Turku, Finland) for testosterone
and estradiol (tailored for postmenopausal condition) and
IRMA kits from Farmos (Oulunsalo, Finland) were pur-
chased for SHBG.
Clinical examination of legs. Two medical research
fellows trained in internal medicine with qualified experi-
ence in angiology together examined all the women. At the
first inspection, with the patient erect, they judged the
varicose veins as trunk varices (dilated trunks of the long or
short saphenous veins or their principal branches), reticular
varices (dilated or tortuous superficial veins that did not
belong to the main trunk or its major branches), or hyphen-
web varices (intradermal varices). During the clinical exam-
ination, the varicose veins were marked with the patient
erect and then with the patient supine and the leg elevated.
The fascial defects, which were often tender, were marked
as possible perforating veins. Subsequently the saphe-
nofemoral junction and the previously marked defects were
controlled by the fingertips and the women were asked to
stand. Control was tested with removal of the fingers in
turn, examining for venous reflux at the fascial defects. This
method of examination has been indicated to be more
effective than the traditional Trendelenburg’s test.9 Subse-
quently, the CEAP classification10 was used to discriminate
the chronic venous diseases of the lower limbs on the basis
of clinical signs, etiology, anatomic involvement of the
superficial, perforating, or deep veins, and pathophysiology
leading to evidence. Duplex scanning of the veins of the
lower limbs was not performed to exclude deep venous
thrombosis. However, all the participants in the study
underwent a plethysmographic study, and all had normal
values of maximum venous outflow, which is a sensitive
marker of venous obstruction.
Plethysmography. On the same morning of the clin-
ical examination, all the women underwent a plethysmo-
graphic examination of lower limb venous capacitance and
outflow. The methodology has been described in detail in a
previous paper.5 However, a brief description of the prin-
cipal points follows. With the patient on an examination
bed with legs slightly elevated to facilitate venous drainage,
two cuffs measuring 22 70 cm were wrapped around the
thighs and two tension detectors (strain-gauge), with un-
stretched length about 90% of the circumference of the
limb, were fixed around the calves at the point of maximum
circumference. The cuffs began to inflate at 50 mm Hg, and
the compression was kept until a relatively stable calf vol-
ume was achieved. The incremental volume represents a
measure of the quantity of blood the examined district is
able to receive because of its distension and is called venous
capacitance or maximal incremental venous volume
(MVIV). MVIV is expressed in mL/100 mL volume.
Limbs with varicose veins have the largest venous capaci-
tance.7 After that, the cuffs were rapidly deflated. The
downward slope is the function of emptying speed of the
previous venous pooling of the leg and is measured as the
maximum venous outflow and expressed in mL/100 mL/
min.
Statistical analysis. Five women were not present at
the venous vessel examination. For two patients, the results
of the sex hormone determination were not available.
Therefore, the final comparisons were based on 97 women.
We tested the association between both the dichotomous
variable varices (yes/no) and the MVIV (upper tertile
versus others) with BMI. Adjustment for age, estradiol,
testosterone, and SHBG values as covariates was performed
in the model because of the relationship of estradiol with
varices shown in this study in the logistic regression analysis
(highest tertile versus others: OR, 3.0; 95% CI, 1.1 to 8.8)
and the correlation of SHBG and testosterone with BMI
shown in the Pearson correlation matrix (0.40; P  .01;
0.21; P .05, respectively). We computed odds ratios and
95% CIs with logistic regression analysis with SPSS Win-
dows 98 release 10.0 (SPSS, Inc, Chicago, Ill).
RESULTS
Descriptive features of the women with trunk varices
(cases) and control subjects are reported in Table I. Of 97
women, 31 (32%) had clinical varices (C2  C3) and 66
(68%) had no visible or palpable signs of venous disease or
only telangiectases or reticular veins (C0  C1).
After the CEAP classification, 55 women had C0 (no
visible or palpable signs of venous disease), 11 had C1
(telangiectases or reticular veins), 29 had C2 (varicose
veins), and two had C3 (edema). Other authors have shown
that only trunk varices are associated in women with leg
symptoms such as heaviness or tension, aching, and itch-
ing,11 so we considered in our data analyses trunk varices
(31 patients) as cases and we added in the control group the
patients with only telangiectases or reticular veins (11 pa-
tients). No skin changes were ascribed to venous disease in
the women participating the study. Ten of 31 women with
varicose veins had telangiectases or reticular veins, too. All
the women had primary varicose veins. Twenty-four of the
women with trunk varices had venous disease only in the
superficial veins, and seven had venous disease in the super-
ficial and perforating veins. The clinical signs and symptoms
of venous dysfunction in all the cases were the result of
reflux.
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The coefficients of intraassay and interassay variations
of eight replicates for each hormone analyzed were: 4.2%
and 12.5% for a testosterone value of 0.420 ng/mL; 5.2%
and 11.1% for an estradiol value of 10 pg/mL; and 3.5%
and 6.7% for an SHBG value of 34.0 nmol/L.5 Quartiles of
BMI were the following: first quartile, 20 to 23 kg/m2;
second quartile, 24 to 26 kg/m2; third quartile, 27 to 29
kg/m2; and fourth quartile, 30 to 42 kg/m2. The women
in the upper quartile of frequency distribution had more
than 30 kg/m2 and were classified as obese. Upper quartile
versus others of BMI was used as independent variable,
with varices and MVIV as dependent variables. The women
with BMI in the upper quartile of the frequency distribu-
tion had a significant association with clinical evidence of
varicose veins, after adjustment for age and serum concen-
tration of estrogens, testosterone, and SHBG (Table II).
Test for linear trend across quartiles was 2 of 4.4 (P .05).
Without the adjustment for testosterone, the results did
not change. The highest quartile of BMI was associated
with clinical evidence of varices with an odds ratio of 5.8
(95% CI, 1.2 to 27.8; P  .05). No association was found
between BMI and MVIV; we tested that association with
both linear regression (considering BMI and MVIV as
continuous variables, R2  .001; P  .7) and logistic
regression (considering MVIV a dichotomous variable and
dividing BMI in quartiles; Table II).
With upper quartiles versus others of waist, hip, and
thigh circumferences as independent variables and presence
of varicose veins as a dependent variable, without adjust-
ments, a significant association was found for hip circum-
ferences (odds ratio, 3.8; 95% CI, 1.1 to 13.5) and for thigh
circumferences (odds ratio, 3.6; 95% CI, 1.0 to 12.9). No
association was detected between waist circumference and
varicose veins (odds ratio, 1.5; 95% CI, 0.4 to 4.9).
DISCUSSION
To our best knowledge, this is the first article that
examines the association between BMI and varicose veins
in a setting that allows the availability of serum concentra-
tion of sex hormones and plethysmographic measurements
of venous capacitance in postmenopausal women. The
prevalence of varicose veins varies among different popula-
tions. Its prevalence is low in African or Australian aborig-
ine populations (0 to 5%)12,13 and is high in Western
countries (25% to 75%).14-17 Different epidemiologic ter-
minology, population sampling, and varicose vein defini-
tions account for much of the variation in the literature. In
this study, we used the CEAP classification of varicose veins
of the lower limbs to permit a comparison of this survey
with other studies.
In an Italian observation, the prevalence of varicose
veins in the elderly population of the Campania region
(1319 subjects; mean age, 74 years) was 35.2% in wom-
en,18 and in agreement with these data, our study reports a
prevalence of varicose veins in 32% of postmenopausal
women. In our data, although women were selected for
high testosterone levels, they had the classical characteris-
tics of a large number of postmenopausal women, such as a
high prevalence of obesity and lower limb varicosity.
We found that obesity (BMI 30 kg/m2) in post-
menopausal women was associated with a higher preva-
lence of varicose veins, whereas no association was found
with the plethysmographic measures of venous capacitance.
A possible explanation of this finding is that obesity could
hamper the normal blood flow exchange between superfi-
cial and deep veins of the lower limbs because of aug-
mented adipose and fibrous tissue surrounding veins. The
increase of adipose tissue disturbs the cutaneous venous
circulation and damages the drainage veins, provoking
stasis and subsequently the appearance of varicose veins.19
According to our results, there is a linear trend of aug-
mented prevalence of varicose veins at increasing levels of
BMI, and for values exceeding 30 kg/m2, there is a signif-
icant excess risk of venous disease in menopause. The
association between higher BMI and varicosity still remains
after adjustment for age, estradiol, testosterone, and SHBG
concentrations.
Epidemiologic studies have observed that other factors
could play a role in the development of venous varicosity of
the lower limbs, such as pregnancy, long-standing seden-
tary activities, and positive family history.20-22 Most of
these studies have documented an influence of obesity on
the development of varices, at least in the female gender.
Table I. Characteristics of study participants (97 women)
Control subjects
(n  66)
Cases
(n  31)
P
value
Age (y) 57.5  0.5 56.8  0.7 .43
BMI (kg/m2) 26.4  0.6 28.4  0.9 .06
Waist circumference (cm) 82.8  1.3 85.9  2.2 .21
Hip circumference (cm) 101.6  0.8 104.7  1.4 .04
SBP (mm Hg) 137.6  2.0 139.6  2.7 .57
DBP (mm Hg) 80.8  1.0 79.4  1.5 .42
Estradiol (pg/mL) 9.6  1.2 16.4  4.7 .07
SHBG (nmol/L) 40.8  2.1 43.7  5.2 .54
Testosterone (ng/mL) 0.42  0.01 0.46  0.02 .56
Cholesterol (mg/dL) 244.0  4.2 234.9  8.8 .29
Tryglicerides (mg/dL) 112.1  6.3 122.7  13.9 .42
HDL cholesterol (mg/dL) 49.9  0.9 51.1  3.3 .64
MVO (mL/100 mL/min) 57.7  1.5 76.2  3.8 .001
MVIV (mL/100 mL) 1.9  0.05 2.4  0.1 .001
All values are mean  standard error of mean.
SBP, Systolic blood pressure; DBP, diastolic blood pressure; HDL, high-
density lipoprotein; MVO, maximum venous outflow.
Table II. Odds ratios (95% CI) of varices and MVIV in
relation to BMI
BMI 30 kg/m2
Odds ratio
Crude Adjusted*
Varices (y/n) 3.8 (1.1-13.2) 5.8 (1.2-28.2)
MVIV 2.2 (mL/100 mL) 1.2 (0.4-4.1) 2.0 (0.4-9.1)
*Adjusted for age, estradiol, sex hormone binding globulin, and testoster-
one.
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This study confirms these previous observations, clarifies
that the association between BMI and varicose veins is
independent of sex hormone levels, and suggests that other
physiopathologic mechanisms, different from augmented
venous distensibility, play a role in determining the clinical
evidence of varicose veins in obesity. In women, the re-
gional distribution of fat in obesity is particularly abundant
in the lower abdomen, gluteal region, and thighs, so it is
not surprising that we have found an association between
varicose veins and higher hip and thigh circumferences and
no association with waist circumferences.
Our results suggest that increased body weight plays a
specific and independent role in the development of vari-
cose veins of the lower limbs in selected groups of post-
menopausal women with high testosterone levels and give
more support to the concept that obesity is not a simple risk
factor but a specific distinct disease with cardiovascular
implications. This finding is of clinical interest and provides
another reason to treat overweight patients before a shift to
frank obesity. In most instances, increased body weight is
associated with varicose veins of the lower limbs.
We thank the Association (Attivecomeprima) for hos-
pitality to the study.
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